{"id":233215,"date":"2026-09-07T12:09:19","date_gmt":"2026-09-07T06:39:19","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=233215"},"modified":"2026-09-07T12:09:20","modified_gmt":"2026-09-07T06:39:20","slug":"is-alpa-laboratories-a-good-buy-after-q1-fy27-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/is-alpa-laboratories-a-good-buy-after-q1-fy27-results\/","title":{"rendered":"Is Alpa Laboratories a Good Buy After Its Q1 FY27 Results?"},"content":{"rendered":"
<\/div>\n

Alpa Laboratories share price around Rs 64. 35.7% below 52-week high of Rs 99. Q1 FY27 revenue Rs 30 crore, down 4.3% YoY. PAT Rs 0.98 crore, down 91.7%. PE 33x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Alpa Laboratories’ Q1 FY27 results were mixed, with revenue at Rs 30 crore but PAT falling 92% to Rs 0.98 crore. The Alpa Laboratories share price near Rs 64 has not escaped this pressure, and the profit decline is the key data point investors should weigh before deciding whether Alpa Laboratories is a good buy right now.<\/p>\n<\/div>\n

The Alpa Laboratories share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Alpa Laboratories is a manufacturer of pharmaceutical formulations, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.<\/p>\n

Revenue for the quarter came in at Rs 30 crore, down 4.3% year on year, while profit after tax came in at Rs 0.98 crore, down 91.7% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Alpa Laboratories share price from here.<\/p>\n

This piece works through the quarter’s financial highlights, the business factors behind the numbers, where the Alpa Laboratories share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n